IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $291,365 | -71.9% | 30,256 | -69.3% | 0.00% | -100.0% |
Q1 2023 | $1,035,641 | -75.9% | 98,445 | -71.6% | 0.00% | -71.4% |
Q4 2022 | $4,289,530 | -17.4% | 346,209 | -31.0% | 0.01% | -22.2% |
Q3 2022 | $5,196,000 | +1673.4% | 501,577 | +1876.6% | 0.01% | – |
Q2 2022 | $293,000 | -35.0% | 25,376 | -27.5% | 0.00% | -100.0% |
Q1 2022 | $451,000 | -65.8% | 34,994 | -69.1% | 0.00% | -50.0% |
Q4 2021 | $1,320,000 | -45.1% | 113,234 | -38.5% | 0.00% | -50.0% |
Q3 2021 | $2,404,000 | +1.5% | 184,074 | 0.0% | 0.00% | +33.3% |
Q2 2021 | $2,369,000 | +116.1% | 184,074 | +87.7% | 0.00% | +200.0% |
Q1 2021 | $1,096,000 | -56.8% | 98,045 | -56.0% | 0.00% | -50.0% |
Q4 2020 | $2,536,000 | +152.8% | 222,666 | +106.5% | 0.00% | 0.0% |
Q3 2020 | $1,003,000 | – | 107,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |